MARKET

NTUS

NTUS

Natus Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

32.91
+0.24
+0.73%
After Hours: 32.91 0 0.00% 16:15 05/20 EDT
OPEN
32.83
PREV CLOSE
32.67
HIGH
32.93
LOW
32.64
VOLUME
231.10K
TURNOVER
0
52 WEEK HIGH
33.93
52 WEEK LOW
20.90
MARKET CAP
1.14B
P/E (TTM)
88.16
1D
5D
1M
3M
1Y
5Y
Natus Medical Q1 EPS $0.22 Misses $0.26 Estimate, Sales $119.80M Beat $115.70M Estimate
Natus Medical (NASDAQ:NTUS) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of $0.26 by 15.38 percent. This is a 37.5 percent increase over earnings of $0.16 per share from the
Benzinga · 05/05 20:43
Natus Medical Q1 Non-GAAP EPS, Revenue Rise
MT Newswires · 05/05 16:34
-- Earnings Flash (NTUS) NATUS MEDICAL INCORPORATED Reports Q1 EPS $0.22, vs. Street Est of $0.26
MT Newswires · 05/05 16:31
Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Nektar Therapeutics Shares Slide
U.S. stocks traded higher in volatile session, with the Dow Jones gaining around 60 points toward the end of trading on Monday.
Benzinga · 04/18 18:34
VIRX, ARQQ and GWGH among mid-day movers
Gainers: Casa Systems (CASA) +67%. CEL-SCI Corporation (CVM) +55%. Natus Medical (NTUS) +29%. Frequency Therapeutics (FREQ) +26%. GWG Holdings (GWGH) +20%. IMARA (IMRA) +19%. Iveda Solutions (IVDA) +18%. AgriFORCE (AGRI) +18%. Maris-Tech
Seekingalpha · 04/18 16:37
Mid-Day Market Update: U.S. Stocks Turn Lower; Bank of America Earnings Top Views
U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Monday.
Benzinga · 04/18 16:36
34 Stocks Moving In Monday's Mid-Day Session
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions.
Benzinga · 04/18 16:13
Mid-Morning Market Update: Markets Open Higher; Dow Gains 100 Points
U.S. stocks traded higher this morning, with the Dow Jones adding around 100 points on Monday.
Benzinga · 04/18 14:55
More
No Data
Learn about the latest financial forecast of NTUS. Analyze the recent business situations of Natus Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average NTUS stock price target is 36.00 with a high estimate of 36.00 and a low estimate of 36.00.
High36.00
Average36.00
Low36.00
Current 32.91
EPS
Actual
Estimate
0.120.230.350.47
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 265
Institutional Holdings: 35.85M
% Owned: 103.67%
Shares Outstanding: 34.59M
TypeInstitutionsShares
Increased
60
1.22M
New
16
1.98M
Decreased
63
3.06M
Sold Out
10
74.40K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.36%
Healthcare Equipment & Supplies
+0.36%
Key Executives
Non-Executive Chairman/Independent Director
Joshua Levine
President/Chief Executive Officer/Director
Thomas Sullivan
Chief Financial Officer/Executive Vice President/IR Contact Officer
B. Drew Davies
Executive Vice President
Austin Noll
Independent Director
Ilan Daskal
Independent Director
Eric Guerin
Independent Director
Lisa Heine
Independent Director
Bryant Moore
Independent Director
Alice Schroeder
No Data
No Data
About NTUS
Natus Medical Incorporated provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The Company provides product solutions for three end markets: Neuro, Newborn Care and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care and neurosurgery. Its Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management and various disposable newborn care supplies. Its Hearing portfolio includes products for hearing assessment and diagnostics and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Balance portfolio provides diagnosis and assessment of vestibular and balance disorders.

Webull offers kinds of Natus Medical Inc stock information, including NASDAQ:NTUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTUS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NTUS stock methods without spending real money on the virtual paper trading platform.